Hims & Hers targeted in FTC lawsuit (update) (HIMS:NYSE) - Seeking Alpha

What the report says

Seeking Alpha reported that Hims & Hers Health, the NYSE-listed telehealth company trading under HIMS, came under pressure after the U.S. Federal Trade Commission filed a lawsuit against the company. According to the publisher’s brief report, the case concerns the company’s business practices and includes allegations involving the sharing of health-related data with online advertising platforms.

The article said Hims & Hers shares declined following the news. The available source material does not include the text of the complaint, the court where it was filed, the remedies the FTC is seeking, or any response from Hims & Hers. Those details would be important for assessing the scope of the allegations and the company’s legal position.

Hims & Hers operates a consumer-facing digital health platform that connects users with services and treatments across areas such as sexual health, dermatology, mental health and weight management. Because such platforms can collect sensitive personal and medical information, allegations about how user data is handled are likely to draw close scrutiny from regulators, investors and customers.

More broadly, the FTC has authority to challenge practices it views as unfair or deceptive, including in areas involving privacy, advertising and consumer disclosures. Based on the limited information published by Seeking Alpha, the immediate significance is both legal and market-related: the lawsuit introduces regulatory risk for Hims & Hers while raising questions about data practices in the online health sector.